Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track LITS with free AI briefings, catalyst countdowns, and dilution alerts.

LITS · Lite Strategy, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$5.7M Cash on Hand

12.8mo Cash Runway

Follow LITS by email Get an email when LITS pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about LITS, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

LITS holds $5.7M in cash and short-term investments (as of Jun 30, 2026) and burns about $1.3M/quarter from operations, an estimated runway of 12.8 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 18 · Low

Cash runway 13 months +18

Recent financing filings on SEC EDGAR:

Sep 15, 2025 · Private placement (8-K Item 3.02) · 8-K
Jul 30, 2025 · Private placement (8-K Item 3.02) · 8-K
Jul 22, 2025 · Private placement (8-K Item 3.02) · 8-K

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LITS files for a raise →

Get the full LITS picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LITS and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z